ROCHESTER MEDICAL CORPORATION 4
4 · ROCHESTER MEDICAL CORPORATION · Filed Nov 18, 2013
Insider Transaction Report
Form 4
Grinde Sarah L.
VP, Development and Research
Transactions
- Award
Common Stock
2013-11-14+8,476→ 21,699 total - Disposition to Issuer
Common
2013-11-14$20.00/sh−21,699$433,980→ 0 total
Footnotes (4)
- [F1]On November 14, 2013 the restricted stock units vested, in accordance with the related award agreements and the Agreement and Plan of Merger dated September 3, 2013 (the "Merger Agreement") among Rochester Medical Corporation (the "Company"), C.R. Bard, Inc., a New Jersey Corporation ("Bard"), and a wholly owned subsidiary of Bard, upon the effectiveness of the merger contemplated by the Merger Agreement (the "Merger") and were simultaneously cancelled in exchange for the right to receive a cash payment of $20.00 for each unit, without interest and less any applicable withholding taxes.
- [F2]Includes restricted stock awards.
- [F3]On November 14, 2013 at the effective time of the Merger, these shares of Company common stock were cancelled and converted into the right to receive a cash payment of $20.00 per share, without interest and less any applicable withholding taxes.
- [F4]Pursuant to the Merger Agreement, upon the effectiveness of the Merger 12,000 shares of restricted stock were cancelled in exchange for the right to receive $20.00 per share, without interest and less any applicable withholding taxes.